CN104474202B - A kind of pharmaceutical composition for the treatment of anorexia - Google Patents

A kind of pharmaceutical composition for the treatment of anorexia Download PDF

Info

Publication number
CN104474202B
CN104474202B CN201410728850.3A CN201410728850A CN104474202B CN 104474202 B CN104474202 B CN 104474202B CN 201410728850 A CN201410728850 A CN 201410728850A CN 104474202 B CN104474202 B CN 104474202B
Authority
CN
China
Prior art keywords
parts
pharmaceutical composition
anorexia
spleen
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410728850.3A
Other languages
Chinese (zh)
Other versions
CN104474202A (en
Inventor
李凤月
任继风
谈洪蕾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao Central Hospital
Original Assignee
Qingdao Central Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao Central Hospital filed Critical Qingdao Central Hospital
Priority to CN201410728850.3A priority Critical patent/CN104474202B/en
Publication of CN104474202A publication Critical patent/CN104474202A/en
Application granted granted Critical
Publication of CN104474202B publication Critical patent/CN104474202B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284Atractylodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/29Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A61K36/296Epimedium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/34Campanulaceae (Bellflower family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/39Convolvulaceae (Morning-glory family), e.g. bindweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/62Nymphaeaceae (Water-lily family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734Crataegus (hawthorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/894Dioscoreaceae (Yam family)
    • A61K36/8945Dioscorea, e.g. yam, Chinese yam or water yam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps

Abstract

The invention belongs to medical art, be specifically related to a kind of pharmaceutical composition for the treatment of anorexia.Described pharmaceutical composition comprises following component: the Rhizoma Atractylodis Macrocephalae, Rhizoma dioscoreae, Pericarpium Citri Reticulatae, Herba Epimedii, Fructus Crataegi, the Radix Astragali, Semen Euryales, Semen Cuscutae, Flos Albiziae, Radix Platycodonis.Pharmaceutical composition of the present invention is Chinese herbal medicine, and its mature preparation process, raw material are easy to get, for all kinds of common anorexia particularly the spleen and stomach in children qi-deficiency type apositia determined curative effect, treating both the principal and secondary aspects of a disease, side effect is little, without recurrence after treatment, can effectively cure apositia patient.

Description

A kind of pharmaceutical composition for the treatment of anorexia
Technical field
The invention belongs to medical art, be specifically related to a kind of pharmaceutical composition for the treatment of anorexia.
Background technology
Anorexia refers to that individual long-term loss of appetite or anorexia are main symptom.Anorexia patient, often once hearing Nausea and vomiting of having a meal, always saying and oneself not starving.Patient is early stage in morbidity, only has the phenomenon lost weight, still can normally work and study.Owing to seeing that food is not coveted, inappetence, very then refusing to eat, continued weight decline, severe patient is with malnutrition, the reactions such as frequent appearance dizziness, giddy, dim eyesight hypoglycemia, slightly movable just perspiration, alopecia, edema, hypotension, hypothermia, bradycardia, even Water-Electrolyte and acid-base balance disorder.Patient does not have enough owing to deliberately digging appetite processed for a long time simultaneously, and digestive juice secretion reduces, and causes appetite to reduce further.
Affected children ranges is treated timely and effectively as can not get, and can cause malnutrition, concurrent vitamin D deficiency, repeatedly exhales the diseases such as respiratory tract infection.Treatment with western mostly is the balance of correcting Water-Electrolyte, and the mode supplementing digestive enzyme such as normal employing is oral, dead point, trace element, the chemosynthesis class medicines such as antibiotic, side effect is large, and patient dependence is poor.Chinese traditional treatment anorexia has rich experience, dialectically distinguishes the disease being located in the spleen or at stomach.Stomach person, based on deficiency of stomach-Yin, card is shown in anorexia and xerostomia polydipsia, constipation with dry stool, red tongue with a little fluid.Spleen person, be good for based on the mistake of spleen fortune, card is shown in anorexia, lustreless complexion, abdominal distention loose stool, pale tongue with white fur.Total Therapeutic Principle is strong activating the spleen gas, yin nourishing stomach reinforcing, uses Chinese prescription, dialectically treats, and determined curative effect, side effect is little, so the Chinese medicine composition studying effective treatment apositia is very necessary.
Summary of the invention
The invention provides a kind of new pharmaceutical composition for the treatment of anorexia, this pharmaceutical composition is rapid-action, good effect, and toxic and side effects is little, and it is obtained by following raw material: the Rhizoma Atractylodis Macrocephalae, Rhizoma dioscoreae, Pericarpium Citri Reticulatae, Herba Epimedii, Fructus Crataegi, the Radix Astragali, Semen Euryales, Semen Cuscutae, Flos Albiziae, Radix Platycodonis.
In pharmaceutical composition of the present invention, the described Rhizoma Atractylodis Macrocephalae, bitter, sweet, temperature.Return spleen, stomach warp.Invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis, antiabortive.For insufficiency of the spleen lack of appetite, abdominal distention is had loose bowels, phlegm retention vertigo and palpitation, edema, spontaneous perspiration, frequent fetal movement.Rhizoma Atractylodis Macrocephalae spleen invigorating, stomach function regulating, antiabortive.For insufficiency of the spleen lack of appetite, loose stool of having loose bowels, frequent fetal movement.
Rhizoma dioscoreae, sweet, flat.Return spleen, lung, kidney channel.Spleen reinforcing nourishing the stomach, promote the production of body fluid lung benefiting, the kidney invigorating arresting seminal emission.For insufficiency of the spleen lack of appetite, incessant chronic diarrhea, the deficiency of the lung is breathed with cough, emission due to deficiency of the kidney, leukorrhagia, frequent micturition, and deficiency-heat is quenched one's thirst.Rhizoma Dioscoreae (parched with bran) spleen reinforcing stomach invigorating.For insufficiency of the spleen lack of appetite, loose stool of having loose bowels, leukorrhagia.
Pericarpium Citri Reticulatae, bitter, pungent, temperature.Return lung, spleen channel.Regulating qi-flowing for strengthening spleen, drying dampness to eliminate phlegm.For fullness in the epigastrium and chest, lack of appetite and vomiting, cough with copious phlegm.
Herba Epimedii, acrid, sweet, warm.Return liver, kidney channel.Kidney-replenishing, bone and muscle strengthening, wind-damp dispelling.For impotence and seminal emission, muscles and bones flaccidity is soft, rheumatic arthralgia, numbness contracture; Climacteric hypertension.
Fructus Crataegi, sour, sweet, tepor.Return spleen, stomach, Liver Channel.Promoting digestion and invigorating the stomach, circulation of qi promoting dissipating blood stasis.For meat stagnation, gastral cavilty distension, dysentery is suffered from abdominal pain, blood stasis amenorrhea, postpartum stagnation, trusted subordinate's twinge, hernia pain; Hyperlipemia.The effect of Fructus Crataegi (parched to brown) dyspepsia and intestinal stasis relieving strengthens.For meat stagnation, dysentery is not well.
The Radix Astragali, sweet, temperature.Return lung, spleen channel.Invigorating QI to consolidate the body surface resistance, diuresis poison holding, evacuation of pus, expelling pus and promoting granulation.Weak for the deficiency of vital energy, anorexia and loose stool, sinking of QI of middle-JIAO, chronic diarrhea proctoptosis, metrorrhagia of having blood in stool, exterior deficiency spontaneous perspiration, deficiency of vital energy edema, carbuncle difficulty is burst, and burst for a long time and do not hold back, blood deficiency dull yellowish colored skin, interior-heat is quenched one's thirst.
Semen Euryales is sweet, puckery, flat.Return spleen, kidney channel.Supplementing the kidney to control the nocturnal, spleen reinforcing antidiarrheal, damp eliminating leukorrhagia stopping.For emission, enuresis frequent micturition, insufficiency of the spleen chronic diarrhea, nebulousurine, leukorrhagia.
Semen Cuscutae, sweet, temperature.Return liver,kidney,spleen warp.Nourishing the liver and kidney, controlling nocturnal emission with astringent drugs reducing urination, antiabortive, improving eyesight, antidiarrheal.For impotence and seminal emission, dripping urination, enuresis frequent micturition, soreness of the waist and knees, blurred vision tinnitus, vaginal bleeding due to deficiency of the kidney during pregnancy, frequent fetal movement, spleen is suffered from a deficiency of the kidney and is rushed down.
Flos Albiziae, sweet, flat.GUIXIN, Liver Channel.Resolving stagnation for tranquilization.For irritability, melancholy insomnia.
Radix Platycodonis, bitter, pungent, flat.Return lung meridian.Lung qi dispersing, sore-throat relieving, eliminates the phlegm, evacuation of pus.For cough with copious phlegm, uncomfortable in chest not smooth, pharyngalgia, hoarseness, lung abscess vomiting pus, skin infection difficulty in discharging of pus.
Apositia is commonly encountered diseases, frequently-occurring disease.Basic pathogenesis is dysfunction of the spleen in transportation, stomach mistake is received, taste are become estranged.Control when invigorating the spleen and benefiting QI, hold up spleen to help fortune, the present invention is to adjust gastrointestinal function, and adjustment mechanism of qi is to make transporting and transforming function of the spleen and stomach vigorous, and QI and blood biochemistry is active.In side, the Rhizoma Atractylodis Macrocephalae, Rhizoma dioscoreae play the merit of invigorating spleen and reinforcing stomach is altogether monarch drug; Pericarpium Citri Reticulatae, regulating qi-flowing for strengthening spleen, Herba Epimedii, regulating QI to relieve pain, reinforcing the kidney and supporting YANG, needle warming moxibustion, the two is ministerial drug altogether; Hawthorn digesting amasss, change the stagnant stasis of blood, Radix Astragali benefiting QI for strengthening the superficies, and Semen Euryales, Semen Cuscutae spleen reinforcing antidiarrheal are adjuvant drug; Flos Albiziae, Radix Platycodonis resolving depression lung qi dispersing are for making medicine.In a word, all medicines share, and spleen invigorating helps fortune, help digestion and in, dyspepsia and intestinal stasis relieving is played, the merit of regulating QI to expel dampness altogether by full side, be basic with invigorating the spleen and stomach, harmonizing the functional activities of vital QI, with tonifying the spleen and stomach and the worry without indigestion, can manage it stagnant gas, and without wound melancholy just, harmonization of the stomach then can be received, spleen is strong then can transporting, spleen stomach invigorating and then anorexia can heal, reach and promote patient's appetite, improve the simultaneous phenomenons such as the mental status is not good, abdominal pain and distension, stool abnormity, qi-deficiency of spleen and stomach apositia can be cured from basic.
The technical scheme adopted for solving its technical problem is the pharmaceutical composition of described treatment anorexia, be made up of the medicine material of following weight: Rhizoma Atractylodis Macrocephalae 16-22 part, Rhizoma dioscoreae 13-21 part, Pericarpium Citri Reticulatae 13-19 part, Herba Epimedii 11-15 part, Fructus Crataegi 8-16 part, Radix Astragali 6-16 part, Semen Euryales 5-12 part, Semen Cuscutae 3-11 part, Flos Albiziae 3-6 part, Radix Platycodonis 1-5 part.
The preferred technical solution of the present invention is, described pharmaceutical composition of the present invention is obtained by the raw material of following weight portion: the Rhizoma Atractylodis Macrocephalae 19 parts, Rhizoma dioscoreae 17 parts, Pericarpium Citri Reticulatae 16 parts, Herba Epimedii 13 parts, Fructus Crataegi 12 parts, the Radix Astragali 11 parts, Semen Euryales 9 parts, Semen Cuscutae 7 parts, Flos Albiziae 5 parts, Radix Platycodonis 3 parts.
Present invention also offers the preparation method of described pharmaceutical composition, specifically comprise the steps:
By the raw material Fructus Crataegi of above-mentioned weight portion, Pericarpium Citri Reticulatae, Herba Epimedii, Rhizoma dioscoreae, the Radix Astragali, Flos Albiziae, Semen Euryales, the Rhizoma Atractylodis Macrocephalae, Semen Cuscutae, Radix Platycodonis is ground into coarse powder respectively, mix homogeneously, adds gross mass 3 times amount soak by water 2 times, filters after each 30min, the determining alcohol adding filtrate 2 times amount is the alcohol reflux 2 times of 75%, and each 60min, filters, reclaim ethanol, filtrate is concentrated into thick paste, obtains final product.
Those skilled in the art directly can be used as medicine on obtained active constituents of medicine basis of the present invention to take or add on pharmaceutics acceptable adjuvant routinely technique be prepared into required preparation.As the oral drugs of the solid dosage form such as conventional tablet (dispersible tablet, effervescent tablet, oral cavity disintegration tablet, buccal tablet, chewable tablet, effervescent tablet), capsule (hard capsule, soft capsule), granule, pill (drop pill), powder can be made, the oral drugs of the liquid forms such as syrup, oral liquid, water preparation, mixture, decoction also can be made.Therefore, in this pharmaceutical composition except effective ingredient, pharmaceutically acceptable adjuvant can also be contained.Preferably, pharmaceutical composition of the present invention conveniently preparation technology be prepared into oral liquid, syrup, pill or powder etc.When using medicine composite for curing apositia of the present invention, take prepared syrup or oral liquid, each 10mL medicinal liquid, 2 times on the one, every milliliter of syrup or oral liquid are containing crude drug amount 0.3g; Or take prepared powder, every bag contains crude drug amount 6g, each half bag, 2 times on the one; Or take prepared pill, every ball contains crude drug amount 1g, each 3,2 times on the one.
The present invention also asks to protect aforementioned pharmaceutical compositions in the purposes of preparation treatment anorexia particularly in preparation treatment qi-deficiency of spleen and stomach anorexia medicine.After by the safety evaluatio of pharmaceutical composition of the present invention, selecting clinical case to observe 94 known treated routine qi-deficiency of spleen and stomach anorexia patients, without coming off case in therapeutic process, all completing clinical observation.After two groups of infants treated for 2 courses for the treatment of, total effects compares, and treatment group cure rate is 44.68%, and matched group is 8.51%, and cure rate compares, and the equal < 0.05 of P value, has significant difference; Total effective rate treatment group is 97.87%, and matched group is 74.47%, and total effective rate compares, and the equal < 0.05 of P value, there were significant differences.Before and after two groups of treatments, routine urinalysis, just routine, liver function, kidney merit, electrocardiogram are without any ANOMALOUS VARIATIONS, have no adverse reaction and those who are allergic to this drug.Result shows that treatment group cure rate and effective percentage are obviously better than matched group, has significant difference.Use medicine composite for curing anorexia of the present invention particularly to treat and belong to qi-deficiency of spleen and stomach anorexia determined curative effect, safe and reliable, can be used as the effective ways for the treatment of qi-deficiency of spleen and stomach anorexia, be worth of widely use in clinical.Simultaneously treatment group is followed up a case by regular visits to 1 year no case was recurrence, treatments period has no adverse reaction.Reach invigorating the spleen and regulating the stomach, dyspepsia and intestinal stasis relieving, the object of regulating QI to expel dampness after thus pharmaceutical composition prescription of the present invention being described, serve the remarkable result for the treatment of both the principal and secondary aspects of a disease.
Pharmaceutical composition of the present invention is natural pure Chinese medicinal preparation, former medicine is easy to get, with low cost, follow the prescriptions principle of the traditional Chinese medical science, untoward reaction and side effect significantly reduce, and safety coefficient is high, verify through clinical practice, its determined curative effect, mild in medicine property and, there is not toxic and side effects and serious adverse reaction, clinical observation total effective rate reaches 100%, can treat anorexia particularly qi-deficiency of spleen and stomach anorexia preferably.Medicine medication prepared by the present invention is simultaneously convenient, improves the compliance of anorexia patient, improves the quality of life of patient.
Detailed description of the invention
Further describe the present invention below by way of specific embodiment, but the present invention is not limited only to following specific embodiment.Within the scope of the invention or not departing from content of the present invention, spirit and scope, the change carried out the present invention, combination or replacement, be apparent for a person skilled in the art, and be included within the scope of the present invention.
Embodiment 1
The each raw material of the present invention is taken: the Rhizoma Atractylodis Macrocephalae 19 parts, Rhizoma dioscoreae 17 parts, Pericarpium Citri Reticulatae 16 parts, Herba Epimedii 13 parts, Fructus Crataegi 12 parts, the Radix Astragali 11 parts, Semen Euryales 9 parts, Semen Cuscutae 7 parts, Flos Albiziae 5 parts, Radix Platycodonis 3 parts by following weight portion.
Preparation technology: the raw material Fructus Crataegi of above-mentioned weight portion, Pericarpium Citri Reticulatae, Herba Epimedii, Rhizoma dioscoreae, the Radix Astragali, Flos Albiziae, Semen Euryales, the Rhizoma Atractylodis Macrocephalae, Semen Cuscutae and Radix Platycodonis are ground into coarse powder respectively, mix homogeneously, add gross mass 3 times amount soak by water 2 times, filter after each 30min, the determining alcohol adding filtrate 2 times amount is the alcohol reflux 2 times of 75%, and each 60min, filters, reclaim ethanol, filtrate is concentrated into thick paste.Those skilled in the art directly can be used as medicine on obtained active constituents of medicine basis of the present invention to take or add on pharmaceutics acceptable adjuvant routinely technique obtain the conventional oral formulations such as oral liquid, syrup, pill or powder.
When using medicine composite for curing apositia of the present invention, take prepared syrup or oral liquid, each 10mL medicinal liquid, 2 times on the one, every milliliter of syrup or oral liquid are containing crude drug amount 0.3g; Or take prepared powder, every bag contains crude drug amount 6g, each 3g, 2 times on the one; Or take prepared pill, every ball contains crude drug amount 1g, each 3 balls, 2 times on the one.
Embodiment 2
The each raw material of the present invention is taken: the Rhizoma Atractylodis Macrocephalae 16 parts, Rhizoma dioscoreae 13 parts, Pericarpium Citri Reticulatae 13 parts, Herba Epimedii 11 parts, Fructus Crataegi 8 parts, the Radix Astragali 6 parts, Semen Euryales 5 parts, Semen Cuscutae 3 parts, Flos Albiziae 3 parts, Radix Platycodonis 1 part by following weight portion.
Embodiment 3
The each raw material of the present invention is taken: the Rhizoma Atractylodis Macrocephalae 22 parts, Rhizoma dioscoreae 21 parts, Pericarpium Citri Reticulatae 19 parts, Herba Epimedii 15 parts, Fructus Crataegi 16 parts, the Radix Astragali 16 parts, Semen Euryales 12 parts, Semen Cuscutae 11 parts, Flos Albiziae 6 parts, Radix Platycodonis 5 parts by following weight portion.
Embodiment 4
The each raw material of the present invention is taken: the Rhizoma Atractylodis Macrocephalae 16 parts, Rhizoma dioscoreae 21 parts, Pericarpium Citri Reticulatae 13 parts, Herba Epimedii 15 parts, Fructus Crataegi 8 parts, the Radix Astragali 16 parts, Semen Euryales 5 parts, Semen Cuscutae 11 parts, Flos Albiziae 3 parts, Radix Platycodonis 5 parts by following weight portion.
Embodiment 5
The each raw material of the present invention is taken: the Rhizoma Atractylodis Macrocephalae 22 parts, Rhizoma dioscoreae 13 parts, Pericarpium Citri Reticulatae 19 parts, Herba Epimedii 11 parts, Fructus Crataegi 16 parts, the Radix Astragali 6 parts, Semen Euryales 12 parts, Semen Cuscutae 3 parts, Flos Albiziae 6 parts, Radix Platycodonis 1 part by following weight portion.
The preparation technology of embodiment 2-5 is with embodiment 1.
The clinical observation of embodiment 6 medicine composite for curing apositia of the present invention
1, case-data: anorexia (qi-deficiency of spleen and stomach) infant 94 the meeting inclusive criteria example selecting pediatric hospital ward and outpatient clinic.The method of employing random packet, parallel control is studied.
Institute includes in the object of observation, treatment group: 47 examples, wherein man 24 example, female 23 example, age 2-14 year, course of disease 2-12 month, slight 0 example, moderate 30 example, severe 17 example.Matched group: 47 examples, wherein man 22 example, female 25 example, age 2-14 year, course of disease 2-12 month, slight 0 example, moderate 29 example, severe 18 example.Two groups of sexes, age, the course of disease, state of an illness etc. through statistical procedures through statistical procedures, compare there was no significant difference (P>0.05), have comparability.
2, diagnosis basis:
1) Western medicine diagnose standard:
(1) long-term inappetence, is shown in that food is not coveted, and reduces more than 1/3-1/2 before appetite is more sick, gets rid of other system disease;
(2) body weight increases stagnation or slows down, and has Bad Eating Habit or improper feeding history.
2) tcm diagnosis standard:
(1) long-term inappetence, and without other diseases person.
(2) lustreless complexion, body is partially thin, but spirit is fair, swollen without abdomen.
(3) have improper feeding history, as feed without at regular time and quantity, eating cold and uncooked food excessively, sweet savoury, snacks or monophagia etc.
3) TCM syndrome diagnostic criteria: qi-deficiency of spleen and stomach
Main symptom: loss of appetite, appetite reduces.
Secondary card: 1. shallow complexion, emaciated physique;
2. spiritlessness and sparing of words, fatigue and asthenia, muscle is soft;
3. defecate shapeless or press from both sides indigestion food;
4. easily perspire;
5. abdominal distention after meal;
6. pale tongue, white and thin fur;
7. arteries and veins is unable or fingerprint is purple stagnant, existing in FENGGUAN.
4) symptom and sign scalar quantization standard: infantile anorexia Syndrome Scale standard: work out with reference to the infantile anorexia grading method in " new Chinese medicine guideline of clinical investigations " (trying) that National Drug Administration promulgates.
Infantile anorexia cardinal symptom scalar quantization table
Infantile anorexia minor symptom scalar quantization table
3, inclusive criteria:
(1) primary disease diagnostic criteria person is met;
(2) the syndrome of deficiency of spleen qi and stomach qi person in primary disease tcm syndrome standard is met;
(3) age 2-14 year, male or female;
(4) test did not use dyspepsia and intestinal stasis relieving medicine and digestant in first 1 week;
(5) the experimenter guardian person that signs Informed Consent Form.
4, exclusion standard:
(1) primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hemopoietic system are associated with, psychotic;
(2) fail to detest trencherman caused by eliminating other system disease;
(3) known maybe may to trial drug and component allergy sufferers thereof.
5, to reject and the standard that comes off:
(1), after case is selected in, find not meet inclusive criteria or meet exclusion standard person;
(2) there is serious adverse events, judge to stop this case clinical trial person according to doctor;
(3) case selected after data not entirely or not by specifying medication person, and to affect the treatment or safety judgement person.
6, usage and dosage:
Treatment group: oral liquid prepared by Example 5, each serving using 10mL medicinal liquid, 2 times on the one, every milliliter of syrup is containing crude drug amount 0.3g.
Matched group: valiant fighter's extract powder (accurate word Z42020712, the 10g*12 bag of traditional Chinese medicines), boiled water is taken after mixing it with water, 2-5 year each 10g, every day 3 times; 6-14 year each 15g, every day 3 times.
Within 14 days, be 1 course for the treatment of, two groups were all used in conjunction for 2 courses for the treatment of.
7, efficacy evaluation:
(1) fully recover: symptom is removed completely, and appetite and appetite return to normal level, and symptom integral rate of descent is more than or equal to 95%;
(2) effective: symptom basic solution removes, and appetite is clearly better, appetite returns to 3/4 of previous level, and symptom integral rate of descent is more than or equal to 70%;
(3) effective: appetite is improved, and appetite is recovered to some extent, but does not reach 3/4 of previous level, and symptom integral rate of descent is more than or equal to 30%;
(4) invalid: appetite and appetite are showed no obviously to be improved or increase the weight of to some extent, and symptom integral rate of descent is less than 30%.
8, therapeutic effect:
Without coming off case in therapeutic process, all complete clinical observation.After two groups of infants treated for 2 courses for the treatment of, total effects compares, and treatment group cure rate is 44.68%, and matched group is 8.51%, and cure rate compares, and the equal < 0.05 of P value, has significant difference; Total effective rate treatment group is 97.87%, and matched group is 74.47%, and total effective rate compares, and the equal < 0.05 of P value, there were significant differences.Before and after two groups of treatments, routine urinalysis, just routine, liver function, kidney merit, electrocardiogram are without any ANOMALOUS VARIATIONS, have no adverse reaction and those who are allergic to this drug.Result shows that treatment group cure rate and effective percentage are obviously better than matched group, has significant difference.Use medicine composite for curing anorexia of the present invention particularly to treat and belong to qi-deficiency of spleen and stomach anorexia determined curative effect, safe and reliable, can be used as the effective ways for the treatment of qi-deficiency of spleen and stomach anorexia, be worth of widely use in clinical.
The comparitive study for the treatment of group and matched group

Claims (8)

1. treat the pharmaceutical composition of anorexia for one kind, it is characterized in that, it is obtained by the crude drug of following weight portion: Rhizoma Atractylodis Macrocephalae 16-22 part, Rhizoma dioscoreae 13-21 part, Pericarpium Citri Reticulatae 13-19 part, Herba Epimedii 11-15 part, Fructus Crataegi 8-16 part, Radix Astragali 6-16 part, Semen Euryales 5-12 part, Semen Cuscutae 3-11 part, Flos Albiziae 3-6 part, Radix Platycodonis 1-5 part.
2. pharmaceutical composition as claimed in claim 1, it is characterized in that, it is obtained by the crude drug of following weight portion: the Rhizoma Atractylodis Macrocephalae 19 parts, Rhizoma dioscoreae 17 parts, Pericarpium Citri Reticulatae 16 parts, Herba Epimedii 13 parts, Fructus Crataegi 12 parts, the Radix Astragali 11 parts, Semen Euryales 9 parts, Semen Cuscutae 7 parts, Flos Albiziae 5 parts, Radix Platycodonis 3 parts.
3. pharmaceutical composition as claimed in claim 1 or 2, it is characterized in that, described pharmaceutical composition is oral formulations.
4. pharmaceutical composition as claimed in claim 3, it is characterized in that, described oral formulations is oral liquid, syrup, pill or powder.
5. pharmaceutical composition as claimed in claim 4, it is characterized in that, described oral formulations is oral liquid.
6. prepare a method for pharmaceutical composition as claimed in claim 3, it is characterized in that, comprise the steps: the crude drug Fructus Crataegi of above-mentioned weight portion, Pericarpium Citri Reticulatae, Herba Epimedii, Rhizoma dioscoreae, the Radix Astragali, Flos Albiziae, Semen Euryales, the Rhizoma Atractylodis Macrocephalae, Semen Cuscutae, Radix Platycodonis is ground into coarse powder respectively, mix homogeneously, adds gross mass 3 times amount soak by water 2 times, filters after each 30min, the determining alcohol adding filtrate 2 times amount is the alcohol reflux 2 times of 75%, each 60min, filters, and reclaims ethanol, filtrate is concentrated into thick paste, obtains final product.
7. the purposes of pharmaceutical composition as claimed in claim 1 or 2 in preparation treatment anorexia medicine.
8. the purposes of pharmaceutical composition as claimed in claim 1 or 2 in preparation treatment the spleen and stomach in children qi-deficiency type anorexia medicine.
CN201410728850.3A 2014-12-04 2014-12-04 A kind of pharmaceutical composition for the treatment of anorexia Expired - Fee Related CN104474202B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410728850.3A CN104474202B (en) 2014-12-04 2014-12-04 A kind of pharmaceutical composition for the treatment of anorexia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410728850.3A CN104474202B (en) 2014-12-04 2014-12-04 A kind of pharmaceutical composition for the treatment of anorexia

Publications (2)

Publication Number Publication Date
CN104474202A CN104474202A (en) 2015-04-01
CN104474202B true CN104474202B (en) 2016-02-17

Family

ID=52748903

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410728850.3A Expired - Fee Related CN104474202B (en) 2014-12-04 2014-12-04 A kind of pharmaceutical composition for the treatment of anorexia

Country Status (1)

Country Link
CN (1) CN104474202B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105748826A (en) * 2016-04-08 2016-07-13 北京御心堂生物科技股份有限公司 Traditional Chinese medicine composition for regulating spleen-stomach disharmony as well as oral liquid and preparation method thereof
CN106110084A (en) * 2016-08-31 2016-11-16 瑞普(天津)生物药业有限公司 A kind of Chinese medicine composition for treating pet dog anorexia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101822764A (en) * 2010-01-18 2010-09-08 郑延明 External patch for treating children anorexia and preparation method thereof
CN103341115A (en) * 2013-07-16 2013-10-09 冯宇伟 Medicine for treating spleen-stomach deficiency of children and preparation method thereof

Also Published As

Publication number Publication date
CN104474202A (en) 2015-04-01

Similar Documents

Publication Publication Date Title
CN102178912B (en) Chinese medicine preparation for relieving gastral cavity crymodynia symptoms of people with yang deficiency as well as preparation method and application thereof
CN106474418A (en) For treating Chinese medicine composition of gastropathy and preparation method thereof
CN101766774A (en) Chinese medicine composite for treating duodenal ulcer and preparation method thereof
CN104288651A (en) Medicine for treating postpartum hypogalactia and preparation method thereof
CN105535577A (en) Medicament to reduce the side effects of chemotherapy for tumor patient
CN103463357A (en) Medicinal liquor capable of warming and invigorating kidney yang and preparing method thereof
CN104474204A (en) Pharmaceutical composition for treating infantile diarrhea
CN104474202B (en) A kind of pharmaceutical composition for the treatment of anorexia
CN106362111A (en) Pharmaceutical composition for improving phlegm-dampness constitution, medicine brick and preparation method of medicine brick
CN105194295A (en) Medicine composition for treating diabetes
CN104548029A (en) Pharmaceutical composition for treating epigastric pain
CN106266693A (en) The Chinese medicine composition for the treatment of diabetes
CN105106734A (en) Traditional Chinese medicine preparation for treating hyperemesis gravidarum
CN105169189A (en) Medicament for treating hypothyroidism
CN105148096A (en) Chinese herb composition for treating cough and preparation method thereof
CN104887950A (en) Mastitis treatment traditional Chinese medicine compound
CN104547553A (en) Traditional Chinese medicine for treating nervous endocrine disorder
CN104225016A (en) Drug composition for treating spleen and stomach deficiency type chronic atrophic gastritis
CN101897935A (en) Chinese medicinal composition for treating gastrolithiasis
CN106421411A (en) Stomach tonifying functional beverage
CN105412823A (en) Pharmaceutical preparation for treating male climacteric syndrome
CN104491571A (en) Medicament for treating throat pain and thirst and preparation method thereof
CN104906298A (en) Traditional Chinese medicine preparation for treating simple obesity and preparation method of traditional Chinese medicine preparation
CN104491640A (en) Pharmaceutical composition for treating functional dyspepsia
CN104906385A (en) Traditional Chinese medicine composition for treating diarrhoea

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C41 Transfer of patent application or patent right or utility model
CB03 Change of inventor or designer information

Inventor after: Li Fengyue

Inventor after: Ren Jifeng

Inventor after: Tan Honglei

Inventor before: Liu Qingxiang

COR Change of bibliographic data
TA01 Transfer of patent application right

Effective date of registration: 20160113

Address after: 266000 No. four, No. 127 South Road, Shandong, Qingdao

Applicant after: Zhongxin Hospital, Qingdao

Address before: Qin village 277799 Shandong city of Linyi province Lanling County No. 149 Bian Zhen

Applicant before: Zou Shidong

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160217

Termination date: 20161204

CF01 Termination of patent right due to non-payment of annual fee